Header for print stylesheet
Go

Press releases 2008

16-Apr-2008DSM Biologics and Upfront to Develop A Fully Disposable Chromatography System Optimized for High Yield Cell Line Production

DSM Biologics, a business unit of DSM Pharmaceutical Products, and Upfront Chromatography A/S, a leading developer of customized industrial-scale separation services, today announced the collaboration between the two companies to optimize Upfront’s new, fully disposable chromatography system for use with DSM's proprietary manufacturing technology.

17-Mar-2008DSM Biologics and Crucell Announce Additional PER.C6® Licensing Agreement with MorphoSys AG

DSM Biologics, a business unit of DSM Pharmaceutical Products and Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced that German-based MorphoSys AG has decided to extend the PER.C6® technology licensing agreement entered in September 2004, exercising an option for clinical and commercial production of antibodies.

11-Mar-2008DSM and Crucell Announce PER.C6® Technology Milestone

DSM Biologics, a business unit of DSM Pharmaceutical Products and Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) announced today that another important milestone has been achieved with the PER.C6® technology platform for the production of monoclonal antibodies and recombinant proteins.

20-Feb-2008DSM Pharmaceuticals, Inc. Change in Management

DSM Pharmaceuticals, Inc. a business unit of DSM Pharmaceutical Products has announced today Mr. Hans Engels has been appointed to the position of President and Business Unit Director of DSM Pharmaceuticals, Inc.

14-Feb-2008100 years after discovery: first industrial production of PharmaPLE™ – a breakthrough for pharma applications at DSM

DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, has successfully launched PharmaPLE™ during the Informex tradeshow in New Orleans. PharmaPLE™ is a recombinant pig liver esterase, which has been scaled and applied successfully in the synthesis of pharma intermediates

05-Feb-2008DSM and APT Pharmaceuticals, Inc. Enter into an Agreement

DSM Pharmaceuticals, Inc. a business unit of DSM Pharmaceutical Products and APT Pharmaceuticals, Inc. announced today they have signed a manufacturing agreement.

21-Jan-2008DSM Pharma Chemicals and DSM Anti-Infectives Awarded the Gold DSM Innovation Award 2007

DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products and DSM Anti-Infectives are pleased to announce today the DSM team has been awarded the Gold DSM Innovation Award 2007.

09-Jan-2008DSM Celebrates its Many Successes

DSM recently celebrated being awarded the North Carolina International Community and Economic Development Award, an award given by the N.C. Department of Commerce in recognition of the important civic and philanthropic contributions made by foreign-owned businesses.

07-Jan-2008DSM and the FDA Join Together for Innovative Partnership in PAT

DSM Pharmaceuticals Inc. and the Food and Drug Administration (FDA) have recently signed an agreement to collaborate on a project involving Statistical Quality by Design Methodology during Pharmaceutical Manufacturing.

News archive

News 2007
News 2006

footer for print stylesheet